Halozyme Therapeutics | DEBITO



Debt Cambiamento Data
Acadia Pharmaceuticals USD 56.29M 56.29M 2025-06
Agios Pharmaceuticals USD 48.76M 48.76M 2025-06
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Amarin USD 0 0 2025-03
Amgen USD 56.2B 1.18B 2025-06
Baxter International USD 10.31B 2.82B 2025-03
Cytokinetics USD 658.13M 1.01M 2025-03
DBV Technologies USD 8.29M 8.29M 2025-06
Eli Lilly USD 39.9B 1.39B 2025-06
Halozyme Therapeutics USD 1.51B 1.65M 2025-06
Ionis Pharmaceuticals USD 1.42B 169.27M 2025-06
MannKind USD 46.82M 243.3M 2025-06
Pfizer USD 60.93B 1.18B 2025-06
United Therapeutics USD 200M 100M 2025-03


Halozyme Therapeutics DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.